Nautilus Biotechnolgy (NAUT) Earnings Date & Reports
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NAUT is expected to report earnings to rise 27.27% to -14 cents per share on November 03
Q3'26
Est.
$-0.14
Q2'26
Beat
by $0.04
Q1'26
Beat
by $0.05
Q4'25
Beat
by $0.03
Q3'25
Beat
by $0.04
The last earnings report on July 28 showed earnings per share of -10 cents, beating the estimate of -15 cents. With 418.07K shares outstanding, the current market capitalization sits at 113.51M.